Rxi Pharmaceuticals Corp (NASDAQ:RXII)

2.73
Delayed Data
As of Apr 18
 -0.02 / -0.73%
Today’s Change
2.51
Today|||52-Week Range
7.70
-50.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues71.0K34.0K19.0K15.0K
 
 
 
 
 
Depreciation And Amortization87.0K77.0K53.0K70.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses8.8M10.2M9.0M9.3M
 
 
 
 
 
Research And Development5.7M6.9M5.4M5.4M
 
 
 
 
 
Total Operating Expenses8.9M10.3M9.0M9.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.8M-10.2M-9.0M-9.4M
 
 
 
 
 
Extraordinary Charge--0.000.00-4.7M
 
 
Other Expenses9.0K-2.0K6.0K-2.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.8M-10.2M-9.0M-14.1M
 
 
 
 
 
Income Taxes0.000.000.00-1.6M
 
 
Preferred Dividend-4.1M-209.0K-2.1M0.00
 
 
 
 
Net Income-8.8M-10.2M-9.0M-12.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS163.6K497.0K674.6K2.3M
 
 
 
 
 
Shares To Calculate EPS Diluted163.6K497.0K674.6K2.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$79.00-$21.00-$16.40-$5.52
 
 
 
 
 
EPS Diluted-$79.00-$21.00-$16.40-$5.52